Cognitive Behavioral Therapy for Suicidal Thoughts in Older Adults
(ANSWERS-OA Trial)
Trial Summary
What is the purpose of this trial?
This trial is testing an online therapy to help older adults with insomnia and suicidal thoughts. The therapy aims to improve sleep by changing negative thoughts and habits around sleep. By doing so, it may also reduce suicidal thoughts and improve cognitive function.
Will I have to stop taking my current medications?
If you are taking psychotropic medications (like antidepressants or sleep aids), you must not have changed the dose in the past 6 weeks and agree not to change it during the trial. If you are not on such medications, you need to be medication-free for at least 6 weeks before starting the trial and agree not to start any new medications during the trial.
What data supports the effectiveness of the treatment Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) for suicidal thoughts in older adults?
Research shows that Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) is effective in reducing insomnia severity, improving sleep quality, and enhancing overall well-being. Additionally, it has been found to reduce symptoms of depression, anxiety, and suicidal thoughts, which suggests it may be beneficial for older adults experiencing suicidal thoughts.12345
Is digital cognitive behavioral therapy for insomnia safe for humans?
How is Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) unique in treating suicidal thoughts in older adults?
Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) is unique because it is a scalable, internet-based treatment that not only addresses insomnia but also improves depression, anxiety, and suicidal thoughts, which are often linked to poor sleep. Unlike traditional therapies, dCBT-I can be accessed online, making it more accessible and convenient for older adults.138910
Research Team
Michael A Grandner, PhD
Principal Investigator
University of Arizona
Eligibility Criteria
This trial is for English-speaking individuals aged 65 or older with insomnia and recent suicidal thoughts. They must be willing to share information between the research team and their mental health provider, not work night shifts, have internet access, and not plan to change psychotropic medications during the trial.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 8 weeks of digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) or are placed in a waitlist control group with weekly monitoring
Crossover Treatment
Participants in the waitlist control group crossover to receive 8 weeks of dCBT-I, while those initially receiving dCBT-I undergo active monitoring
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 6- and 12-months post-treatment
Treatment Details
Interventions
- Digital Cognitive Behavioral Therapy for Insomnia (Behavioral Intervention)
Digital Cognitive Behavioral Therapy for Insomnia is already approved in Canada for the following indications:
- Insomnia
Find a Clinic Near You
Who Is Running the Clinical Trial?
MICHAEL A GRANDNER
Lead Sponsor
University of Pennsylvania
Collaborator
Dr. Joan Lau
University of Pennsylvania
Chief Executive Officer since 2020
PhD in Neuroscience from the University of Cincinnati College of Medicine, MBA from the Wharton School of Business, BS in Bioengineering from the University of Pennsylvania
Dr. Robert Iannone
University of Pennsylvania
Chief Medical Officer since 2019
MD from Yale University, MSCE from the University of Pennsylvania